DE69116135D1 - Verwendung von alpha-tocopherolphosphat oder eines derivates davon zur herstellung kosmetischer dermatologischer oder pharmazeutischer präparate - Google Patents

Verwendung von alpha-tocopherolphosphat oder eines derivates davon zur herstellung kosmetischer dermatologischer oder pharmazeutischer präparate

Info

Publication number
DE69116135D1
DE69116135D1 DE69116135T DE69116135T DE69116135D1 DE 69116135 D1 DE69116135 D1 DE 69116135D1 DE 69116135 T DE69116135 T DE 69116135T DE 69116135 T DE69116135 T DE 69116135T DE 69116135 D1 DE69116135 D1 DE 69116135D1
Authority
DE
Germany
Prior art keywords
alpha
radical
methyl
hydrogen atom
tocopherolphosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69116135T
Other languages
English (en)
Other versions
DE69116135T2 (de
Inventor
Alain Meybeck
Frederic Bonte
Christian Marechal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LVMH Recherche GIE
Original Assignee
LVMH Recherche GIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9393284&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69116135(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LVMH Recherche GIE filed Critical LVMH Recherche GIE
Publication of DE69116135D1 publication Critical patent/DE69116135D1/de
Application granted granted Critical
Publication of DE69116135T2 publication Critical patent/DE69116135T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02—Preparations containing skin colorants, e.g. pigments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/002—Aftershave preparations
DE69116135T 1990-01-31 1991-01-30 Verwendung von alpha-tocopherolphosphat oder eines derivates davon zur herstellung kosmetischer dermatologischer oder pharmazeutischer präparate Expired - Lifetime DE69116135T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9001143A FR2657526B1 (fr) 1990-01-31 1990-01-31 Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues.
PCT/FR1991/000055 WO1991011189A1 (fr) 1990-01-31 1991-01-30 UTILISATION D'UN PHOSPHATE D'α-TOCOPHEROL, OU DE L'UN DE SES DERIVES, POUR LA PREPARATION DE COMPOSITIONS COSMETIQUES, DERMATOLOGIQUES, OU PHARMACEUTIQUES; COMPOSITIONS AINSI OBTENUES

Publications (2)

Publication Number Publication Date
DE69116135D1 true DE69116135D1 (de) 1996-02-15
DE69116135T2 DE69116135T2 (de) 1996-08-29

Family

ID=9393284

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69116135T Expired - Lifetime DE69116135T2 (de) 1990-01-31 1991-01-30 Verwendung von alpha-tocopherolphosphat oder eines derivates davon zur herstellung kosmetischer dermatologischer oder pharmazeutischer präparate
DE69128653T Expired - Lifetime DE69128653T2 (de) 1990-01-31 1991-01-30 Verwendung von Alphatocopherol phosphate oder eines Derivates davon zur Herstellung kosmetischer, dermatologischer oder pharmazeutischer Präparate mit anti-radikaler Aktivität und Zusammensetzungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69128653T Expired - Lifetime DE69128653T2 (de) 1990-01-31 1991-01-30 Verwendung von Alphatocopherol phosphate oder eines Derivates davon zur Herstellung kosmetischer, dermatologischer oder pharmazeutischer Präparate mit anti-radikaler Aktivität und Zusammensetzungen

Country Status (11)

Country Link
US (3) US5387579A (de)
EP (2) EP0652010B1 (de)
JP (1) JP3186763B2 (de)
AT (1) ATE132370T1 (de)
CA (1) CA2075201C (de)
DE (2) DE69116135T2 (de)
DK (1) DK0513104T3 (de)
ES (2) ES2114645T3 (de)
FR (1) FR2657526B1 (de)
GR (1) GR3019341T3 (de)
WO (1) WO1991011189A1 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657526B1 (fr) * 1990-01-31 1994-10-28 Lvmh Rech Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues.
FR2679904A1 (fr) * 1991-08-01 1993-02-05 Lvmh Rech Utilisation d'un phosphate de tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, ou pharmaceutiques et compositions ainsi obtenues.
US5643597A (en) * 1991-08-01 1997-07-01 Lvmh Recherche Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained
KR950007045B1 (ko) * 1992-04-14 1995-06-30 주식회사태평양 폴리에톡실레이티드 비타민 e를 함유한 피부화장료
US5350775A (en) * 1992-07-20 1994-09-27 Showa Denko K.K. Benzopyran derivative, method for producing the same and use thereof
CA2179940A1 (en) * 1995-07-18 1997-01-19 Kazumi Ogata Antiallergic composition comprising a phosphoric diester compound
FR2747044B1 (fr) * 1996-04-03 1998-06-26 Coletica Utilisation de graines de vegetaux apres germination comme source de superoxyde dismutase et compositions cosmetiques, pharmaceutiques ou agroalimentaires contenant une telle superoxyde dismutase vegetale, et procede d'extraction
FR2754713B1 (fr) 1996-10-22 1999-01-08 Roc Sa Utilisation de complexes pour la preparation de compositions pour le traitement des peaux sensibles, procede de preparation et compositions hypoallergeniques
US6022867A (en) * 1996-11-27 2000-02-08 Showa Denko Kabushiki Kaisha Method of administering vitamin E to animals and compositions containing tocopheryl phosphates and salts thereof for animals
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
DE19713368A1 (de) * 1997-03-29 1998-10-01 Beiersdorf Ag Zubereitungen mit oxidationsempfindlichen Wirkstoffen
US7030155B2 (en) * 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6716451B1 (en) * 1999-11-30 2004-04-06 Soft Gel Technologies, Inc. Formulation and delivery method to enhance antioxidant potency of vitamin E
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
CA2426885C (en) * 2000-11-14 2010-06-29 Vital Health Sciences Pty Ltd Complexes of phosphate derivatives
CN100396287C (zh) * 2000-11-14 2008-06-25 生命健康科学有限公司 含有电子转移剂磷酸盐衍生物的制剂
WO2002043765A2 (en) * 2000-11-28 2002-06-06 Transform Pharmaceuticals, Inc. Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
AU2002317053B2 (en) * 2001-07-27 2004-08-05 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
US20040092428A1 (en) * 2001-11-27 2004-05-13 Hongming Chen Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
HUP0501186A2 (en) * 2001-12-03 2006-05-29 Novacea Pharmaceutical compositions comprising active vitamin d compounds
CN1604772A (zh) * 2001-12-13 2005-04-06 生命健康科学有限公司 化合物的透皮转运
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
US20050220733A1 (en) * 2002-05-09 2005-10-06 Showa Denko K.K. Skin whitening external preparation
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US7329688B2 (en) * 2002-12-17 2008-02-12 Soft Gel Technologies, Inc. Natural vitamin E compositions with superior antioxidant potency
AU2003296454A1 (en) * 2002-12-19 2004-07-29 Access Business Group International Llc Increasing skin cell renewal with water-soluble vitamin e
US6645514B1 (en) * 2002-12-19 2003-11-11 Access Business Group International, Llc Increasing skin cell renewal with water-soluble Vitamin E
US20060241085A1 (en) * 2003-01-17 2006-10-26 West Simon M Compounds having anti-proliferative properties
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
TWI262798B (en) * 2003-12-31 2006-10-01 Ind Tech Res Inst Liposome and drug deliver system
DK1720551T3 (da) * 2004-03-03 2011-05-16 Vital Health Sciences Pty Ltd Alkaloidformuleringer
CA2575587C (en) * 2004-08-03 2014-06-17 Vital Health Sciences Pty Ltd Carrier for enteral administration
JP4523388B2 (ja) * 2004-11-19 2010-08-11 日本メナード化粧品株式会社 コラーゲン合成促進剤及び皮膚外用剤
WO2006092024A1 (en) * 2005-03-03 2006-09-08 Vital Health Sciences Pty Ltd Compounds having anti-cancer properties
US20090239827A1 (en) * 2005-03-03 2009-09-24 Esra Ogru Compounds having lipid lowering properties
JP5221343B2 (ja) * 2005-06-17 2013-06-26 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 担体
CN101247834B (zh) * 2005-06-17 2013-10-30 生命健康科学公司 包含一种或多种二-和/或单-（电子转移剂）磷酸酯衍生物或其络合物的载体
FR2891736B1 (fr) * 2005-10-12 2007-11-30 Gattefosse Sas Soc Par Actions Excipient comprenant un derive de cires pour la fabrication de formulations topiques cosmetiques
WO2007070981A1 (en) * 2005-12-23 2007-06-28 Vital Health Sciences Pty Ltd Compounds having cytokine modulating properties
JP4684906B2 (ja) * 2006-02-09 2011-05-18 日本メナード化粧品株式会社 タイトジャンクション形成促進剤
CN101431995B (zh) 2006-02-21 2012-02-01 玫琳凯有限公司 稳定的维生素c组合物
JP4675801B2 (ja) * 2006-03-06 2011-04-27 日本メナード化粧品株式会社 Ｒｏｒ活性化剤
JP4781855B2 (ja) * 2006-03-08 2011-09-28 日本メナード化粧品株式会社 複合粉体及び当該複合粉体を含有するメイクアップ化粧料
JP4675806B2 (ja) * 2006-03-16 2011-04-27 日本メナード化粧品株式会社 アネキシン活性化剤
FR2921259B1 (fr) * 2007-09-26 2015-02-13 Lvmh Rech Utilisation cosmetique du phosphate de tocopherol comme agent anti-vieillissement de la peau
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
JP5546809B2 (ja) * 2009-07-09 2014-07-09 日本メナード化粧品株式会社 乳化化粧料
RU2577233C2 (ru) * 2009-12-23 2016-03-10 Фосфейдженикс Лимитед Композиция носителя
EP2531047A4 (de) 2010-02-05 2014-03-19 Phosphagenics Ltd Träger mit einem nichtneutralisierten tocopherylphosphat
AU2011235597B2 (en) 2010-03-30 2015-07-16 Phosphagenics Limited Transdermal delivery patch
FR2969924B1 (fr) 2010-12-30 2013-11-15 Lvmh Rech Composition comprenant un phosphate de tocopherol
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
EP3287138A1 (de) * 2012-08-23 2018-02-28 Agila Specialties Private Limited Verbesserte injizierbare daptomycinformulierung
FR3015247B1 (fr) 2013-12-20 2016-12-23 Lvmh Rech Utilisation du phosphate de tocopherol comme agent hydratant
JP6339376B2 (ja) * 2014-02-13 2018-06-06 株式会社ファンケル 化粧料
JP6882321B2 (ja) 2015-12-09 2021-06-02 フォスファージニクス リミテッド 医薬製剤
CN110662733A (zh) 2016-12-21 2020-01-07 埃维科生物技术有限公司 方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144325A (en) * 1976-11-10 1979-03-13 Voyt Walter F Method of and composition for preventing sunburn while affording tanning
JPS5944375A (ja) * 1982-09-06 1984-03-12 Senjiyu Seiyaku Kk α−トコフエロ−ルリン酸エステルの安定な水溶液
JPS59219295A (ja) * 1983-05-30 1984-12-10 Senjiyu Seiyaku Kk リン酸ジエステルまたはその塩およびそれらの製造法
DE3586859D1 (de) * 1984-03-07 1993-01-07 Roshdy Ismail Mittel zur behandlung und zum schutz der haut.
RO89761A2 (ro) * 1984-03-19 1986-07-30 Institutul Oncologic,Ro Medicament destinat cresterii imunitatii cu suport celular si tratamentului unor afectiuni maligne si virale
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
JPS62265299A (ja) * 1985-12-18 1987-11-18 Senjiyu Seiyaku Kk α―トコフェロールとウリジンとのリン酸ジエステル，そのハロゲン置換体もしくはこれらの塩およびそれらの製造法
JPS62145019A (ja) * 1985-12-19 1987-06-29 Senjiyu Seiyaku Kk 抗炎症剤
JPS62205091A (ja) * 1986-03-04 1987-09-09 Senjiyu Seiyaku Kk 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤
JP2526059B2 (ja) * 1987-04-28 1996-08-21 千寿製薬株式会社 抗潰瘍剤
DE3883246T2 (de) * 1987-10-19 1993-12-02 Liposome Co Inc Auf tocopherol basierte arzneimittelsysteme.
US5198432A (en) * 1988-01-29 1993-03-30 Center For Innovative Technology Method of preventing chlorohydrocarbon toxicity using sterol derivatives
FR2628317B1 (fr) * 1988-03-09 1991-11-08 Lvmh Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant
US5100654A (en) * 1989-04-07 1992-03-31 Yale University Phosphorylated derivatives of l-dopa and compositions and methods for increasing the melanin content in mammalian skin and hair
US5516788A (en) * 1989-06-22 1996-05-14 University Of Bath Tetrahydroindenoindole compounds useful in the treatment of conditions associated with free radical formation
FR2657526B1 (fr) * 1990-01-31 1994-10-28 Lvmh Rech Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues.
US5652274A (en) * 1991-03-01 1997-07-29 Martin; Alain Therapeutic-wound healing compositions and methods for preparing and using same
FR2679904A1 (fr) * 1991-08-01 1993-02-05 Lvmh Rech Utilisation d'un phosphate de tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, ou pharmaceutiques et compositions ainsi obtenues.
US5643597A (en) * 1991-08-01 1997-07-01 Lvmh Recherche Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained

Also Published As

Publication number Publication date
GR3019341T3 (en) 1996-06-30
CA2075201C (en) 2003-12-02
ES2114645T3 (es) 1998-06-01
EP0652010B1 (de) 1998-01-07
DK0513104T3 (da) 1996-05-20
FR2657526B1 (fr) 1994-10-28
US5656618A (en) 1997-08-12
ES2084808T3 (es) 1996-05-16
JP3186763B2 (ja) 2001-07-11
CA2075201A1 (en) 1991-08-01
DE69128653D1 (de) 1998-02-12
JPH05505393A (ja) 1993-08-12
EP0513104B1 (de) 1996-01-03
US5952001A (en) 1999-09-14
EP0652010A1 (de) 1995-05-10
EP0513104A1 (de) 1992-11-19
DE69128653T2 (de) 1998-07-23
ATE132370T1 (de) 1996-01-15
WO1991011189A1 (fr) 1991-08-08
FR2657526A1 (fr) 1991-08-02
DE69116135T2 (de) 1996-08-29
US5387579A (en) 1995-02-07

Similar Documents

Publication Publication Date Title
DE69116135T2 (de) Verwendung von alpha-tocopherolphosphat oder eines derivates davon zur herstellung kosmetischer dermatologischer oder pharmazeutischer präparate
DE69415445T2 (de) Zytotoxische Stilben-Derivate und diese enthaltende pharmazeutische Zusammensetzungen
ATE122355T1 (de) 2-substituierte adenosinderivate und pharmazeutische zusammensetzungen zur verwendung gegen infektionskrankheiten.
NZ240189A (en) Aryl substituted amides, carbamates, carbonates, ketones and esters; preparation and pharmaceutical/cosmetic compositions thereof
DE69207194D1 (de) Verfahren zur Herstellung von Bacchatin III und von Desacetyl-10-Bacchatin III Derivate
ATE101120T1 (de) N-substituierte lauramide, ihre herstellung und sie enthaltende zusammensetzungen.
ATE177950T1 (de) Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis
DE69119875D1 (de) Verwendung von Dioxabicyclo [3.3.0]octane Derivaten zur Herstellung eines Arzneimittels zur Hemmung des Cholesterinmetabolismus.
DE69001515T2 (de) Urethan-derivate, ihre herstellung und verwendung als hautbefeuchtendes mittel in kosmetischen und pharmazeutischen zubereitungen zur behandlung trockener haut.
ATE155140T1 (de) 3-deoxyoligosacchariden, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ES2133511T3 (es) Composicion tintorea que contiene p-fenilendiaminas con azufre, p-fenilendiaminas con azufre y su procedimiento de preparacion.
PT96164A (pt) Processo de preparacao de uma composicao farmaceutica a base de derivados de fluoroquinolona
ES2032501T3 (es) Un procedimiento de preparacion de derivados de urileno-2,4,6-triamino-3-oxido.
DE69015787T2 (de) Thiophenderivate, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
ATE121405T1 (de) Oxazolopyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
FI954138A (fi) Hydroksimetyylifuratsaanikarboksyylihappojohdannaiset ja niiden käyttö sydänverisuonitautien käsittelyssä
HUP9803028A2 (hu) Ciklusos nitronok és az azokat hatóanyagként tartalmazó gyógyszerkészítmények
ATE147755T1 (de) Dipeptidderivate und diese als aktive bestandteile enthaltendes prophylaktisches oder therapeutisches mittel gegen knochenkrankheiten
ATE184282T1 (de) Cyclopropan-derivate und diese enthaltende antivirale mittel
DE68902627D1 (de) Verwendung von chromanderivaten zur herstellung eines medikamentes zur behandlung von depressiven zustaenden.
ATE70050T1 (de) 1-benzoyl-2-oxo-5-alkoxy-pyrrolidin-derivate, ihre herstellung und verwendung als heilmittel und zubereitungen, die sie enthalten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition